Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Gains from Equity Investments (2021 - 2023)

Historic Gains from Equity Investments for INVO Fertility (IVF) over the last 3 years, with Q3 2023 value amounting to $8163.0.

  • INVO Fertility's Gains from Equity Investments fell 6197.95% to $8163.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $22103.0, marking a year-over-year decrease of 9479.46%. This contributed to the annual value of $200558.0 for FY2022, which is 3876.88% down from last year.
  • As of Q3 2023, INVO Fertility's Gains from Equity Investments stood at $8163.0, which was down 6197.95% from -$3788.0 recorded in Q2 2023.
  • INVO Fertility's Gains from Equity Investments' 5-year high stood at $214050.0 during Q4 2021, with a 5-year trough of -$10007.0 in Q4 2022.
  • Its 3-year average for Gains from Equity Investments is $62245.6, with a median of $27735.0 in 2023.
  • Its Gains from Equity Investments has fluctuated over the past 5 years, first plummeted by 10467.51% in 2022, then tumbled by 6100.09% in 2023.
  • INVO Fertility's Gains from Equity Investments (Quarter) stood at $214050.0 in 2021, then tumbled by 104.68% to -$10007.0 in 2022, then soared by 181.57% to $8163.0 in 2023.
  • Its Gains from Equity Investments stands at $8163.0 for Q3 2023, versus -$3788.0 for Q2 2023 and $27735.0 for Q1 2023.